Tumour Cell Density Quantified by Artificial Intelligence Is Associated with Differential Benefit from Irinotecan-Based Chemo-Radiotherapy in Locally Advanced Rectal Cancer: A Post-hoc Study of the Phase 3 ARISTOTLE Trial

Shen, Z., Brand, D., Simard, M. et al. (8 more authors) (Accepted: 2026) Tumour Cell Density Quantified by Artificial Intelligence Is Associated with Differential Benefit from Irinotecan-Based Chemo-Radiotherapy in Locally Advanced Rectal Cancer: A Post-hoc Study of the Phase 3 ARISTOTLE Trial. EBioMedicine. ISSN: 2352-3964 (In Press)

Metadata

Item Type: Article
Authors/Creators:
Dates:
  • Accepted: 3 July 2026
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Pathology and Data Analytics
Funding Information:
Funder
Grant number
Yorkshire Cancer Research Account Ref: 2UOLEEDS
L386-RA/2015/R2/003
University College London Finance Division
UCL/H0706/65
Cancer Research UK Supplier No: 138573
RRCOER-Jun24/100004
Date Deposited: 23 Jul 2026 15:49
Last Modified: 23 Jul 2026 15:49
Status: In Press
Publisher: Elsevier
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)